Juan Miguel Cejalvo

Also affiliated with Hospital Clínico Universitario de Valencia, Centre for Biomedical Network Research on Rare Diseases, Solti, INCLIVA Health Research Institute, Centro de Investigación Biomédica en Red de Cáncer

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation”.

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

The Lancet Oncology(2020)10.1016/s1470-2045(20)30450-2

N/A

0DataRank · unranked

75 citations

Valentina Guarneri, Laia Paré, Gaia Griguolo, Tomás Pascual, Maria Vittoria Dieci +34 more

Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts

Cancer(2023)10.1002/cncr.34750

N/A

0DataRank · unranked

15 citations

Olga Martínez‐Sáez, Adrienne G. Waks, Alison Laws, Monica McGrath, Paolo Tarantino +11 more